Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-PFT

被引:0
|
作者
Delmas, P. D.
Bauer, D.
Black, D.
Boonen, S. R.
Cosman, F.
Eastell, R.
机构
[1] Univ Lyon 1, Dept Med, F-69365 Lyon, France
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[4] Univ Louvain, Ctr Metab Bone Dis, Louvain, Belgium
[5] Helen Hayes Hosp, Dept Med, W Haverstraw, NY USA
[6] No Gen Hosp, Metab Bone Ctr, Sheffield S5 7AU, S Yorkshire, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S29 / S29
页数:1
相关论文
共 50 条
  • [41] (PREMIER POSTER - AWARD CANDIDATE) EFFECT OF ONCE-YEARLY ZOLEDRONIC ACID 5 MG ON 'SUPER SIX' NON-VERTEBRAL FRACTURES
    Black, D. M.
    Eastell, R.
    Cosman, F.
    McLellan, A.
    Man, Z.
    Bucci-Rechtweg, C.
    Mesenbrink, P.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S281 - S281
  • [42] ANTIFRACTURE EFFICACY AND SAFETY OF ONCE-YEARLY ZOLEDRONIC ACID 5 MG IN MEN WITH OSTEOPOROSIS: A PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL
    Boonen, Steven
    Su, Guoqin
    Incera, Elodie
    Orwoll, Eric
    Kaufman, Jean-Marc
    Reginster, Jean-Yves
    Rizzoli, Rene
    Lippuner, Kurt
    Vanderschueren, Dirk
    Bucci-Rechtweg, Christina
    Antunez, Oscar
    Papanastasiou, Phil
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 112 - 112
  • [43] Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial
    R. Eastell
    T. Lang
    S. Boonen
    S. Cummings
    P. D. Delmas
    J. A. Cauley
    Z. Horowitz
    E. Kerzberg
    G. Bianchi
    D. Kendler
    P. Leung
    Z. Man
    P. Mesenbrink
    E. F. Eriksen
    D. M. Black
    Osteoporosis International, 2010, 21 : 1277 - 1285
  • [44] Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial
    Eastell, R.
    Lang, T.
    Boonen, S.
    Cummings, S.
    Delmas, P. D.
    Cauley, J. A.
    Horowitz, Z.
    Kerzberg, E.
    Bianchi, G.
    Kendler, D.
    Leung, P.
    Man, Z.
    Mesenbrink, P.
    Eriksen, E. F.
    Black, D. M.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (07) : 1277 - 1285
  • [45] Bone Mineral Density (BMD) After Hip Fracture: Variations in Response to Once-Yearly i.v. Zoledronic acid (ZOL) 5 mg
    Magaziner, J.
    Orwig, D.
    Lyles, K. W.
    Nordsletten, L.
    Boonen, S.
    Adachi, J.
    Colon-Emeric, C.
    Bucci-Rechtweg, C.
    Mesenbrink, P.
    Pieper, C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 : S86 - S86
  • [46] Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density
    Eastell, Richard
    Black, Dennis M.
    Boonen, Steven
    Adami, Silvano
    Felsenberg, Dieter
    Lippuner, Kurt
    Cummings, Steven R.
    Delmas, Pierre D.
    Palermo, Lisa
    Mesenbrink, Peter
    Cauley, Jane A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (09): : 3215 - 3225
  • [47] Bisphosphonate-related osteonecrosis of the jaw (BRONJ) associated with a once-yearly IV infusion of zoledronic acid (Reclast) 5 mg: Two cases and review of the literature
    Katz, Joseph
    Ordoveza, Patrisha A.
    QUINTESSENCE INTERNATIONAL, 2014, 45 (08): : 685 - 690
  • [48] Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis
    Delmas, Pierre D.
    Munoz, Francoise
    Black, Dennis M.
    Cosman, Felicia
    Boonen, Steven
    Watts, Nelson B.
    Kendler, David
    Eriksen, Erik F.
    Mesenbrink, Peter G.
    Eastell, Richard
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (09) : 1544 - 1551
  • [49] The Addition of Once-Yearly Zoledronic Acid 5mg to Non-Bisphosphonate Treatment for Osteoporosis Reduced Fractures in Postmenopausal Women: The Horizon-Pivotal Fracture Trial
    Reid, David
    Delmas, Pierre
    Eastell, Richard
    Boonen, Steven
    Cummings, Steven
    Palermo, Lisa
    Cauley, Jane
    Recknor, Chris
    Cosman, Felicia
    Mesenbrink, Peter
    Krieginan, Andrey
    Eriksen, Erik
    Black, Dennis
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1204 - 1205
  • [50] Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density EDITORIAL COMMENT
    Eastell, Richard
    Black, Dennis M.
    Boonen, Steven
    Adami, Silvano
    Felsenberg, Dieter
    Lippuner, Kurt
    Cummings, Steven R.
    Delmas, Pierre D.
    Palermo, Lisa
    Mesenbrink, Peter
    Cauley, Jane A.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2010, 65 (03) : 177 - 178